Munich (ots/PRNewswire) - FOR EU MEDIA ONLY. NOT FOR UK MEDIA. - Daiichi Sankyo announces enrollment of first patient in ETNA-AF-Europe and the commencement of ETNA-VTE-Europe, two regional registries to collect robust information on how once-daily LIXIANA(R) is being used in real world settings - ETNA is a Daiichi Sankyo global initiative which will collect data ...
London (ots/PRNewswire) - A new UK company focused on acquiring, rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health Highly experienced management team; blue chip investors Mereo BioPharma Group Ltd ("Mereo"), a recently-formed speciality ...
Heidelberg (ots) - BioMed X Innovation Center announced today that they have extended their collaboration with Merck Serono, the biopharmaceuticals business of Merck, on new approaches for cancer therapy. Based on the results presented at the biannual meeting on July 10th in Heidelberg, Germany, Merck Serono decided to extend the funding of the first two international research groups for a third year. BioMed X and Merck ...
Calgary, Alberta (ots/PRNewswire) - - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") announced today that it has closed the previously-announced private placement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink") and Eastern Capital Limited ("Eastern"). Under the terms of the transaction, Hepalink subscribed for 13,270,000 units, each unit ...
Hong Kong (ots/PRNewswire) - Study to enroll 436 patients at up to 20 sites throughout China OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has announced that the first patient has been enrolled in the clinical study in China of its COMBO(TM) Dual Therapy Stent. The China Recovery Study is designed to evaluate the ...
Intrepid 24/7 & Ingle International Inc.
Toronto (ots/PRNewswire) - Intrepid 24/7, a global medical, security, and travel assistance company within the Ingle International group of companies, is changing the landscape of business travel with its award-winning, white-labelled native mobile and web application, Travel Navigator(TM). Travel Navigator(TM) was ...
Milan (ots/PRNewswire) - The deal will speed up the commercialization of Xadago(R) for the treatment of Parkinson's Disease Nigaard is a pharmaceutical company well established in Denmark, Norway, Sweden, Iceland and Finland Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic area and the Respiratory area with a focus on Rare Diseases, announced today ...
Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") announced today that it has closed a license agreement and formally entered into a definitive stock purchase agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink"). The closing of the stock purchase ...
Teva Pharmaceutical Industries Ltd.
Amsterdam (ots/PRNewswire) - Teva Pharmaceutical Industries Ltd. today announced that its DuoResp Spiromax(R) inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design that improve the quality of healthcare delivery. DuoResp Spiromax(R) (budesonide/formoterol fumarate dihydrate) is a ...
Nuremberg, Germany (ots/PRNewswire) - - Internationally, only 16 percent of people are completely satisfied with the amount of leisure time they have. - America, Canada and UK have highest percentage of people who are satisfied; Russia and Japan have highest percentage dissatisfied. The busy pace of life is a popular complaint for many people. But findings released by ...
Lyon, France (ots/PRNewswire) - MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD. To view the Multimedia News Release, please click: ...
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the expanded use of Levemir(R) (insulin detemir) in children with diabetes as young as one year old. (Logo: http://photos.prnewswire.com/prnh/20141103/713759 ) There are an estimated 497,100 children living ...
Tokyo (ots/PRNewswire) - Press release not intended for US and UK media - EU approval paves the way for LIXIANA(R) (edoxaban) to be made available across all European member states - Marketing authorisation is based on data from the ENGAGE AF-TIMI 48 and Hokusai-VTE studies, the largest single comparative global ...
Toronto (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the guardian(TM)2 extension ...
Milan (ots/PRNewswire) - The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology. Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM(TM) S-ICD System as the most innovative ...
Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. today announced that following recent meetings with various European regulatory bodies, the first confirmation for our Phase 3 clinical plan has officially been received. A further regulatory and protocol design update will be provided to the market post the approval of additional regulatory ...
Milan (ots/PRNewswire) - Scientific evidence and nutritional advice for a better life At EXPOMilano2015, food and nutrition was discussed during the international meeting "Back to Basics" which was attended by doctors, scientists and senior figures from around the world. Attendees included the Australian Robert Gibson, the Italian Carlo La Vecchia, Briton Sumantra Ray, the South African Christine Venter, the Swiss Luc ...
Tokyo (ots/PRNewswire) - Daiichi Sankyo announces the initiation of Hokusai-VTE Cancer, a multinational study investigating edoxaban in venous thromboembolism (VTE) associated with cancer Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the initiation of Hokusai-VTE Cancer, a multinational ...
Lyon, France (ots/PRNewswire) - The European Commission grants marketing authorization for GARDASIL 9, the only 9-valent HPV vaccine Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorization for GARDASIL 9. GARDASIL 9 is a 9-valent HPV vaccine for active immunization of females and males from the age of 9 years against ...
Lausanne, Switzerland (ots/PRNewswire) - - Applicable to a wide variety of sample types to isolate bacteria, viruses, tumor cells, etc. - FibroTrap improves sensitivity and shortens time taken from sample collection to results - Spinomix to focus on the development of its flagship MagPhase technology Debiopharm ...
Chertsey, England (ots/PRNewswire) - - Results from Phase 1/2 trial investigating drug candidate for rare, aggressive blood cancer announced at European Hematology Association Congress; Phase 3 trial planned for late 2015 Astellas Pharma Europe today announced that preliminary data from a Phase 1/2 trial[a] on the ...
London (ots/PRNewswire) - World Leader In Medical Technology Adopts Field Service Management To Standardise Processes, Drive Efficiency Gains, and Better Organise Global Service Operations ServiceMax [http://www.servicemax.com ], the field service management solution for a new era of business, today announced that it has been selected by IBA (Ion Beam Applications S.A ...
Nuremberg, Germany (ots/PRNewswire) - - Over four out of 10 physicians and six out of 10 patients are not satisfied with the level of control achieved for moderate to severe adult patients treated with high potency topical steroids. - 91 percent of moderate to severe adults receiving high potency topical steroids ...
Montreal (ots/PRNewswire) - - New company DalCor to sponsor global phase III clinical trial to be led by MHI DalCor Pharmaceuticals Canada Inc. (DalCor) and the Montreal Heart Institute (MHI) announced today a collaboration in principle to conduct an international Phase III clinical trial which could result in a ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for US based media - Global Fertility Alliance will identify and work on improvements of fertility-related laboratory processes Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today ...
Boston (ots/PRNewswire) - - 166-OR This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication. New phase 3b findings showed adults with type 2 diabetes treated with Xultophy(R) (IDegLira), a once-daily, single-injection combination of insulin degludec and ...
Boston, Massachusetts (ots/PRNewswire) - This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication Abstract #1121-P New findings showed that adults with type 2 diabetes treated with Victoza(R) , in combination with metformin, experienced similar ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - For Release in Europe Only - Resolor was approved in 2009 in Europe for use in women for the symptomatic treatment of chronic constipation in whom laxatives fail to provide adequate relief[1] Shire plc announced today that Resolor (prucalopride) has been approved by the European ...
Brussels (ots/PRNewswire) - Report[1] recommendations aim to improve management of AF as numbers expected to double from 8.8 to 17.9 million adults aged over 55 years between 2010 and 2060[2] Launched in Brussels today at the start of Heart Rhythm Week (1-7 June 2015) the Future of Anticoagulation Report[1] ...
Calgary, Alberta (ots/PRNewswire) - RVX-208, the first selective bromodomain extra-terminal (BET) protein inhibitor, significantly reduces alkaline phosphatase (ALP) levels in patients with high vascular risk Resverlogix Corp. (the "Company") today announced that new data on RVX-208 was presented at the ERA-EDTA ...